Clinical Trial Update: An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 study evaluating 18F-Fluciclovine PET-CT to measure therapeutic response in metastatic prostate cancer; the trial was terminated and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-Fluciclovine PET-CT (fluciclovine F-18)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 4 | Status: TERMINATED | Results posted: 2025-01-16